What are the guidelines for treating Lyme disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Treating Lyme Disease

For patients with Lyme disease, oral doxycycline (100mg twice daily for 10 days) is the first-line treatment for early localized disease, while specific parenteral regimens are recommended for more severe manifestations involving the nervous system, joints, or heart. 1

Prevention and Prophylaxis

Tick Bite Prevention

  • Use EPA-registered repellents: DEET, picaridin, IR3535, oil of lemon eucalyptus, PMD, 2-undecanone, or permethrin 1
  • Remove attached ticks promptly using fine-tipped tweezers 1
  • Do not burn ticks or apply chemicals to remove them 1

Post-Tick Bite Management

  • Prophylactic antibiotics only recommended for high-risk tick bites meeting ALL criteria:
    • Identified Ixodes species tick
    • Tick attached ≥36 hours
    • Bite occurred in highly endemic area
    • Treatment within 72 hours of tick removal 1
  • Recommended prophylaxis: Single dose of doxycycline (200mg for adults, 4.4mg/kg up to 200mg for children) 1
  • Testing asymptomatic patients after tick bites is not recommended 1

Treatment of Lyme Disease by Stage

Early Localized Disease (Erythema Migrans)

  • First-line treatments (choose one):
    • Doxycycline: 100mg twice daily for 10 days
    • Amoxicillin: 500mg three times daily for 14 days
    • Cefuroxime axetil: 500mg twice daily for 14 days 1
  • Second-line treatment:
    • Azithromycin: 500mg on day 1, then 250mg daily for 4-9 days (7-day course preferred) 1
  • Laboratory testing not required for typical erythema migrans in endemic areas 1

Early Disseminated Disease

  • Multiple erythema migrans without neurologic involvement:

    • Same oral regimens as early localized disease 1, 2
    • Oral doxycycline is as effective as parenteral ceftriaxone for disseminated disease without meningitis 2
  • Neurologic Lyme disease (meningitis, radiculopathy):

    • Preferred: Ceftriaxone 2g IV once daily for 14-21 days 1
    • Alternatives: Cefotaxime 2g IV every 8h or penicillin G 18-24 million units IV daily divided every 4h 1
    • For isolated facial nerve palsy without other neurologic signs: oral regimens may be used 1
  • Lyme carditis:

    • For outpatients with mild carditis: oral antibiotics 1
    • For patients with severe cardiac complications (PR >300ms, arrhythmias, myopericarditis): hospitalization with continuous ECG monitoring 1
    • Temporary pacing for symptomatic bradycardia rather than permanent pacemaker 1

Late Disease (Lyme Arthritis)

  • Initial treatment with oral antibiotics (same as for early disease) 1
  • For persistent arthritis after oral therapy: IV ceftriaxone 2g daily for 14-28 days 1

Special Populations

Children

  • For children ≥8 years: doxycycline is first-line (same as adults) 1
  • For children <8 years: traditionally amoxicillin has been preferred due to concerns about dental staining with doxycycline 1
  • Recent evidence suggests short courses of doxycycline (≤21 days) may be safe in younger children 3, 4
  • Pediatric dosing:
    • Amoxicillin: 50mg/kg/day in 3 divided doses (max 500mg per dose)
    • Doxycycline: 4mg/kg/day in 2 divided doses (max 100mg per dose) 1

Pregnant Women

  • Doxycycline is contraindicated
  • Use amoxicillin, cefuroxime, or IV regimens as appropriate for disease stage 1

Treatment Pitfalls and Caveats

  1. Avoid inappropriate treatments:

    • Do not use first-generation cephalosporins, fluoroquinolones, carbapenems, vancomycin, metronidazole, or combinations of antimicrobials 1
    • Avoid prolonged or repeated courses of antibiotics beyond recommended durations 1
  2. Diagnostic considerations:

    • Do not routinely test for Lyme disease in patients with psychiatric illness or developmental disorders 1
    • In areas where both STARI and Lyme disease are endemic, treat erythema migrans with Lyme disease regimens if the tick species is unknown 1
  3. Coinfection awareness:

    • Consider coinfection with Babesia or Anaplasma in patients with more severe initial symptoms, high-grade fever persisting >48h despite appropriate antibiotics, or unexplained cytopenias 1
  4. Post-treatment symptoms:

    • Persistent symptoms after appropriate treatment may not represent ongoing infection
    • Distinguish between treatment failure and post-Lyme disease syndrome 1, 2
    • Avoid prolonged antibiotic therapy for persistent symptoms when there is no evidence of active infection 1

The evidence strongly supports short-course antibiotic therapy for most manifestations of Lyme disease, with specific regimens based on disease stage and organ involvement.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Doxycycline for the Treatment of Lyme Disease in Young Children.

The Pediatric infectious disease journal, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.